...
首页> 外文期刊>Regulatory Toxicology and Pharmacology: RTP >A weight of evidence approach to investigate potential common mechanisms in pesticide groups to support cumulative risk assessment: A case study with dinitroaniline pesticides
【24h】

A weight of evidence approach to investigate potential common mechanisms in pesticide groups to support cumulative risk assessment: A case study with dinitroaniline pesticides

机译:一种探讨农药群体潜在常见机制的证据方法,以支持累积风险评估:用大硝基苯胺杀虫剂进行案例研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In 2016, the United States Environmental Protection Agency's (EPA) Office of Pesticide Programs published guidelines for establishing candidate common mechanism groups (CMGs) for cumulative risk assessment (CRA) weight-of-evidence-based screenings. A candidate CMG is a group of chemicals that may share similar structure, apical endpoints, and/or mechanistic data that suggest the potential for a common mechanism of toxicity among them. Here, a weight-of-evidence approach is presented to establish candidacy of a CMG for a group of nine dinitroaniline pesticides. This approach involves review of available in vivo toxicity information and literature to determine mode of action, along with analyses of in vitro toxicity data and chemical structure. Despite structural similarity among some dinitroanilines and some shared target organs identified through toxicity observed in in vivo studies, there were no consistencies among groups, suggesting lack of a common mechanism when all analyses are considered together. For example, two structurally similar compounds with thyroid/liver in vivo effects were not found active in any Toxicity Forecaster (ToxCast) in vitro assays. The weight-of-evidence is insufficient to support the testable hypothesis that dinitroanilines could form a CMG, and highlights the importance of establishing a consensus among multiple lines of evidence prior to CRA.
机译:2016年,美国环境保护局(EPA)农药课程办公室公布了建立候选人共同机制群体(CMG)的累积风险评估(CRA)基于证据的基础筛查的准则。候选CMG是一组化学品,可以共享类似的结构,顶点终点和/或机械数据,这表明它们之间存在常见毒性机制的可能性。这里,提出了一种验证方法以建立一组九种二硝基胺农药的CMG的候选。这种方法涉及审查可用体内毒性信息和文献以确定作用方式,以及体外毒性数据和化学结构的分析。尽管某些二硝基胺中的结构相似性和通过体内研究中观察到的毒性鉴定的一些共用目标器官,但群体之间没有一致性,表明所有分析都在一起时缺乏共同的机制。例如,在任何毒性预测(Toxcast)的体外测定中,没有发现具有体内效应的两种结构相似的甲状腺/肝脏的化合物。证据的重量不足以支持可测试的假设,即Dinitroanilines可以形成CMG,并强调在CRA之前在多条证据之间建立共识的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号